Abstract Details

Title Clobazam Response in Patients with Previous Benzodiazepine Use: Subanalysis of the Phase III CONTAIN Trial in Lennox-Gastaut Syndrome (LGS)

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) (-)

Poster/Presentation
Number 252

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Deborah A. Lee, MD, PhD (AlaWai Neurology Consulting LLC) PRESENTER	No disclosure on file
William E. Rosenfeld, MD, FAAN (Comprehensive Epilepsy Care Center for Children and Adults)	The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science.
	No disclosure on file
Jouko I. Isojarvi, MD, PhD (Lundbeck)	No disclosure on file

��ɫ��